These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3095150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M, Koellner G, Yokomatsu T, Shibuya S, Bzowska A.
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human purine nucleoside phosphorylase by acyclic nucleosides and nucleotides.
    Stein JM, Stoeckler JD, Li SY, Tolman RL, MacCoss M, Chen A, Karkas JD, Ashton WT, Parks RE.
    Biochem Pharmacol; 1987 Apr 15; 36(8):1237-44. PubMed ID: 3109438
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanine.
    Shewach DS, Chern JW, Pillote KE, Townsend LB, Daddona PE.
    Cancer Res; 1986 Feb 15; 46(2):519-23. PubMed ID: 3079664
    [Abstract] [Full Text] [Related]

  • 6. Structure-based drug design: inhibitors of purine nucleoside phosphorylase.
    Montgomery JA.
    Farmaco; 1993 Feb 15; 48(2):297-308. PubMed ID: 8494600
    [Abstract] [Full Text] [Related]

  • 7. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
    Toms AV, Wang W, Li Y, Ganem B, Ealick SE.
    Acta Crystallogr D Biol Crystallogr; 2005 Nov 15; 61(Pt 11):1449-58. PubMed ID: 16239721
    [Abstract] [Full Text] [Related]

  • 8. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW, Tyler PC, Furneaux RH, Bagdassarian CK, Schramm VL.
    Biochemistry; 1998 Jun 16; 37(24):8615-21. PubMed ID: 9628722
    [Abstract] [Full Text] [Related]

  • 9. Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
    Evans GB, Furneaux RH, Lewandowicz A, Schramm VL, Tyler PC.
    J Med Chem; 2003 Jul 17; 46(15):3412-23. PubMed ID: 12852771
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.
    Farutin V, Masterson L, Andricopulo AD, Cheng J, Riley B, Hakimi R, Frazer JW, Cordes EH.
    J Med Chem; 1999 Jul 01; 42(13):2422-31. PubMed ID: 10395483
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition of activity of purine nucleoside phosphorylase with N9- and N7-(beta-D-glucofuranuronosyl)purines and 8-substituted N9-(beta-D-ribofuranosyl)purines)].
    Anan'ev AV, Maurin'sh IuA, Paégle RA, Lidak MIu, Akopian ZhI.
    Bioorg Khim; 1991 Jun 01; 17(6):855-6. PubMed ID: 1776970
    [Abstract] [Full Text] [Related]

  • 12. 7-Deazapurine 2'-deoxyribofuranosides are noncleavable competitive inhibitors of Escherichia coli purine nucleoside phosphorylase (PNP).
    Bzowska A, Kazimierczuk Z, Seela F.
    Acta Biochim Pol; 1998 Jun 01; 45(3):755-68. PubMed ID: 9918502
    [Abstract] [Full Text] [Related]

  • 13. 8-Amino-9-substituted guanines: potent purine nucleoside phosphorylase (PNP) inhibitors.
    Sircar JC, Kostlan CR, Pinter GW, Suto MJ, Bobovski TP, Capiris T, Schwender CF, Dong MK, Scott ME, Bennett MK.
    Agents Actions; 1987 Aug 01; 21(3-4):253-6. PubMed ID: 3120506
    [Abstract] [Full Text] [Related]

  • 14. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
    Beauchamp LM, Tuttle JV, Rodriguez ME, Sznaidman ML.
    J Med Chem; 1996 Feb 16; 39(4):949-56. PubMed ID: 8632418
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.
    Glavas-Obrovac L, Suver M, Hikishima S, Hashimoto M, Yokomatsu T, Magnowska L, Bzowska A.
    Chem Biol Drug Des; 2010 Apr 16; 75(4):392-9. PubMed ID: 20102369
    [Abstract] [Full Text] [Related]

  • 16. Inhibitors of human purine nucleoside phosphorylase. Synthesis, purine nucleoside phosphorylase inhibition, and T-cell cytotoxicity of 2,5-diaminothiazolo[5,4-d]pyrimidin-7(6H)-one and 2,5-diaminothiazolo[4,5-d]pyrimidin-7(6H)-one. Two thio isosteres of 8-aminoguanine.
    Sircar JC, Suto MJ, Scott ME, Dong MK, Gilbertsen RB.
    J Med Chem; 1986 Sep 16; 29(9):1804-6. PubMed ID: 3091835
    [Abstract] [Full Text] [Related]

  • 17. Kinetics and crystal structure of human purine nucleoside phosphorylase in complex with 7-methyl-6-thio-guanosine.
    Silva RG, Pereira JH, Canduri F, de Azevedo WF, Basso LA, Santos DS.
    Arch Biochem Biophys; 2005 Oct 01; 442(1):49-58. PubMed ID: 16154528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A, Koellner G, Wielgus-Kutrowska B, Stroh A, Raszewski G, Holý A, Steiner T, Frank J.
    J Mol Biol; 2004 Sep 17; 342(3):1015-32. PubMed ID: 15342253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.